This topic contains a solution. Click here to go to the answer

Author Question: Compared to members of low-context macrosystems, members of high-context macrosystems are more ... (Read 69 times)

Starlight

  • Hero Member
  • *****
  • Posts: 567
Compared to members of low-context macrosystems, members of high-context macrosystems are more likely to
 
  a. try to control nature.
  b. expect personal freedom.
  c. follow traditional role expectations.
  d. have fragmented social relationships.

Question 2

When what is said is more important than who said it, the system is most likely a(n)
 
  a. low-context microsystem.
  b. high-context macrosystem.
  c. low-context macrosystem.
  d. elemental system.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fwbard

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

ANSWER:
c

Answer to Question 2

ANSWER:
c




Starlight

  • Member
  • Posts: 567
Reply 2 on: Sep 15, 2018
Thanks for the timely response, appreciate it


ultraflyy23

  • Member
  • Posts: 312
Reply 3 on: Yesterday
Gracias!

 

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library